Presented by: Jake Glanville, PhD, Distributed Bio

About Episode 5

In episode 5, Jake Glanville shares how he was able to grow his company without outside funding sources and he continually turns his therapeutic innovations into reality.

About Jake Glanville

Jake, Founding Partner and CEO of Distributed Bio, is an entrepreneur and computational immuno-engineer. He has developed multiple seminal methods in the fields of high-throughput antibody repertoire sequencing, repertoire decoding algorithms, single-cell TCR receptor & phenotype sequencing, and computationally guided antibody library engineering.

Ready to collaborate?

Connect with an Advisor


Also Available from the Charles River Innovator’s Series...

Episode 6: The Bridge Model: Stimulating NYC Biotech Innovations from 3 Premier Institutions presented by: William J. Polvino, MD, Bridge Medicines

Episode 6: The Bridge Model: Stimulating NYC Biotech Innovations from 3 Premier Institutions presented by: William J. Polvino, MD, Bridge Medicines.

Drug development is a race – time matters. In episode 6, Bill expands on this idea and shares how a collaboration between academia and private sources can accelerate time to market.


Ready to collaborate?

Connect with an Advisor